Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07321353 · ClinicalTrials.gov registry record · NA
Survivors Journey+
A NA study of Pediatric Brain Tumor, sponsored by Children's Hospital Medical Center, Cincinnati.
- Recruiting
- Registry status
- NA
- Development phase
- 72
- Enrollment target
- 2
- Study locations
NCT07321353: Recruiting NA study of Pediatric Brain Tumor, sponsored by Children's Hospital Medical Center, Cincinnati.
NCT07321353 is a NA study of Pediatric Brain Tumor that is actively recruiting participants, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 72 participants, above the 37-participant average among 9 other Pediatric Brain Tumor trials with a reported enrollment target (95% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07321353, a NA study of Pediatric Brain Tumor, is actively recruiting participants, sponsored by Children's Hospital Medical Center, Cincinnati.
- RECRUITING
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
- 2
- Study locations
Study Summary
The main goal of this pilot randomized controlled trial is to learn if an online program called "Survivors Journey" (SJ+) can help teens and young adults, ages 15-25, who are Pediatric Brain Tumor Survivors (PBTS), and their caregivers, manage everyday challenges better by using skills like problem-solving and coping skills. The main questions it aims to answer are: * Is the SJ+ program rated as feasible (\>50% enrollment rate and \>75% retention rate) and acceptable (\>80% satisfaction rate) by PBTS and their caregivers? * Does the SJ+ program have better outcomes in improving PBTS and caregiver wellbeing in comparison to an internet resource comparison (IRB) made for PBTS and their families? Participants will be randomized into two groups: one group will be given access to the online SJ+ program and receive weekly online coaching sessions, and the other group will be given access to an IRC. Outcomes will be assessed at baseline, treatment completion (\~ 3 months post-baseline), and at follow-up six months post-baseline. These outcomes include quality of life, internalizing symptoms, performance-based executive function skills, depression, and family impact.
Primary Outcome
Minimum score of 0, maximum score of 100. A higher score indicates better Health-Related Quality of Life, which is considered better.
Conditions Studied
Interventions
- BEHAVIORAL Survivor's Journey+
Study Locations (2)
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
- Nationwide Children's Hospital - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2025-08-01 |
| Est. Completion | 2028-09 |
| Phase | NA |
What NCT07321353 shows while recruiting
NCT07321353 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, above the 37-participant average among 9 other Pediatric Brain Tumor trials with a reported enrollment target (95% higher).
The record links to 1 condition, with Pediatric Brain Tumor appearing as the primary indexed condition, and to 1 intervention - of which Survivor's Journey+ is the first listed.
NCT07321353 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT07321353 about?
NCT07321353 is a clinical study titled "Survivors Journey+". The main goal of this pilot randomized controlled trial is to learn if an online program called "Survivors Journey" (SJ+) can help teens and young adults, ages 15-25, who are Pediatric Brain Tumor Survivors (PBTS), and their caregivers, manage everyday challenges better by using skills like problem-...
What is the current status of trial NCT07321353?
This trial is currently recruiting. It is a NA study. The enrollment target is 72 participants. The study started on 2025-08-01. Estimated completion is 2028-09.
What conditions does trial NCT07321353 study?
This clinical trial studies the following conditions: Pediatric Brain Tumor.
What interventions are being tested in trial NCT07321353?
The interventions under investigation include: Survivor's Journey+ (BEHAVIORAL).
Who is sponsoring clinical trial NCT07321353?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07321353 being conducted?
This trial has 2 study locations across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pediatric Brain Tumor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07321353's enrollment target sits among peer trials
72 2nd of 9 the highest of 9 other Pediatric Brain Tumor trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pediatric Brain Tumor trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility/Acceptability of Attentional-Control Training in Survivors
RECRUITING · NA
-
High-Intensity Interval Exercise in Young Adult Survivors of Pediatric Brain Tumors: A Pilot Feasibility Study
RECRUITING · NA
-
Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma
ACTIVE NOT RECRUITING · NA
-
Intra-Tumoral Injections of Natural Killer Cells for Recurrent Malignant Pediatric Brain Tumors
RECRUITING · Phase 1
-
Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)
RECRUITING · Phase 1
-
GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI